1. Home
  2. CYTO vs ALLR Comparison

CYTO vs ALLR Comparison

Compare CYTO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTO
  • ALLR
  • Stock Information
  • Founded
  • CYTO 2003
  • ALLR 2004
  • Country
  • CYTO Bermuda
  • ALLR United States
  • Employees
  • CYTO N/A
  • ALLR N/A
  • Industry
  • CYTO Biotechnology: Pharmaceutical Preparations
  • ALLR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CYTO Health Care
  • ALLR Health Care
  • Exchange
  • CYTO Nasdaq
  • ALLR Nasdaq
  • Market Cap
  • CYTO 2.2M
  • ALLR 2.3M
  • IPO Year
  • CYTO N/A
  • ALLR N/A
  • Fundamental
  • Price
  • CYTO $0.46
  • ALLR $1.32
  • Analyst Decision
  • CYTO
  • ALLR
  • Analyst Count
  • CYTO 0
  • ALLR 0
  • Target Price
  • CYTO N/A
  • ALLR N/A
  • AVG Volume (30 Days)
  • CYTO 106.0K
  • ALLR 658.4K
  • Earning Date
  • CYTO 09-24-2024
  • ALLR 11-14-2024
  • Dividend Yield
  • CYTO N/A
  • ALLR N/A
  • EPS Growth
  • CYTO N/A
  • ALLR N/A
  • EPS
  • CYTO N/A
  • ALLR N/A
  • Revenue
  • CYTO N/A
  • ALLR N/A
  • Revenue This Year
  • CYTO N/A
  • ALLR N/A
  • Revenue Next Year
  • CYTO N/A
  • ALLR N/A
  • P/E Ratio
  • CYTO N/A
  • ALLR N/A
  • Revenue Growth
  • CYTO N/A
  • ALLR N/A
  • 52 Week Low
  • CYTO $0.40
  • ALLR $1.26
  • 52 Week High
  • CYTO $17.20
  • ALLR $666.00
  • Technical
  • Relative Strength Index (RSI)
  • CYTO 35.16
  • ALLR 32.39
  • Support Level
  • CYTO $0.40
  • ALLR $1.32
  • Resistance Level
  • CYTO $0.62
  • ALLR $1.53
  • Average True Range (ATR)
  • CYTO 0.06
  • ALLR 0.12
  • MACD
  • CYTO 0.00
  • ALLR 0.05
  • Stochastic Oscillator
  • CYTO 25.18
  • ALLR 14.63

About CYTO Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Share on Social Networks: